Lupus anticoagulants, anticardiolipin antibodies, and cerebral ischemia

M Kushner1, N Simonian

  • 1Department of Neurology, Hospital of the University of Pennsylvania, Philadelphia 19104.

Stroke
|February 1, 1989
PubMed

Insights

This study found that patients with cerebral ischemia and antiphospholipid antibodies, such as lupus anticoagulant (LA) and anticardiolipin antibodies (ACA), often experience recurrent strokes. Laboratory test results for LA and ACA can be inconsistent, highlighting diagnostic challenges.

Area of Science:

  • Neurology
  • Rheumatology
  • Immunology

Background:

  • Cerebral ischemia is a significant cause of neurological disability.
  • Antiphospholipid antibodies, including lupus anticoagulant (LA) and anticardiolipin antibodies (ACA), are associated with an increased risk of thrombosis.
  • The role of these antibodies in patients with cerebral ischemia requires further elucidation.

Purpose of the Study:

  • To investigate the prevalence and clinical characteristics of cerebral ischemia in patients with laboratory evidence of lupus anticoagulant (LA) or anticardiolipin antibodies (ACA).
  • To assess the association between these antibodies and cerebrovascular events.
  • To evaluate the heterogeneity of laboratory findings in this patient cohort.

Main Methods:

  • Retrospective analysis of 23 patients with cerebral ischemia and positive laboratory tests for LA or ACA.
  • Clinical data collection including medical history, neurological examination, and presence of collagen-vascular disease.
  • Laboratory testing for LA and ACA, including assessment of partial thromboplastin time.

Main Results:

  • 71% of patients experienced multiple cerebral ischemic events; two had multi-infarct dementia.
  • 57% of patients had recognized cerebrovascular disease risk factors.
  • LA was identified in 15/21 patients, and elevated ACA titer in 10/12 patients; assays were discordant in 8/10.
  • Only 35% of patients had a prolonged partial thromboplastin time.

Conclusions:

  • Cerebral ischemia associated with LA and ACA is often recurrent.
  • Other cerebrovascular disease risk factors are frequently present in these patients.
  • Significant heterogeneity exists in laboratory findings for LA and ACA, posing diagnostic challenges.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...